Wednesday, September 25, 2019 - While everyone is paying attention to the price of Truvada ($20,000/yr.) and arguing over the best way to get the drug to those who need it the most (gay black and Latino teenagers), few in media are focusing on the drugs severe side effects and asking the question whether or not the drug should be taken at all. Truvada causes bone density problems and patients develop osteoporosis, a weakening of bone strength. Truvada patients have experienced fractures and breaks due to a lack of bone strength due to Truvada. Most fearful of all is the fact that there is no evidence that bone density loss is reversible when one stops taking Truvada. Experts now warn that bone density loss could be permanent and the percentage of patients suffering permanent bone density loss is also unknown. According to Truvada.com, patients should also be forewarned that taking the drug can lead to "Kidney problems, including kidney failure, too much lactic acid in your blood (lactic acidosis), and severe liver problems, which in rare cases can lead to death." Truvada kidney failure lawyers offer a free no obligation consultation before filing a claim.
Truvada is 99% effective in stopping the transmission of HIV however it does little more than using a condom and engaging in a monogamous relationship accomplishes. In that sense, Truvada picks up where personal responsibility and morality leave off. In addition to the bone density loss side effects that Truvada carries, the drug's promotion is coming under criticism. Gilead is accurately promoting the drug's use in existing relationships as a way to enhance safe sex practices and prevent the spread of HIV, but the narrative may also be cultivating a false sense of security and leading to a more promiscuous lifestyle. Truvada's effectiveness if made available for free could make having multiple sexual partners more acceptable as well as encourage less safe sex. Those on Truvada would naturally be willing to take the risk of not using a condom and expose themselves to other sexually transmitted diseases. By inadvertently encouraging more sexual activity the demand for Truvada may also skyrocket.
Lawsuits have been filed on behalf of Truvada patients that have experienced bone breakage and fractures from routine falls and that Gilead Sciences, maker of Truvada, knew the risks and failed to warn patients. Truvada initially warned patients that bone density loss could be a side effect for those with a pre-existing bone density condition. Also, Gilead may have deliberately kept Descovy, a Truvada alternative drug from consumers. Descovy is thought to be safer and more effective than Truvada. Gilead had a plan to seamlessly switch their patients from Truvada to Descovy once the Truvada patent expired by offering millions of bottles of Truvada free of charge. The Truvada/Descovy marketing switch is scheduled once Truvada's patent expires and will effectively inhibit low-priced generic competition.
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.